Ad is loading...
BNXTF
Price
$0.17
Change
+$0.01 (+6.25%)
Updated
Nov 15 closing price
SDZXF
Price
$44.83
Change
-$0.80 (-1.75%)
Updated
Nov 15 closing price
108 days until earnings call
Ad is loading...

BNXTF vs SDZXF

Header iconBNXTF vs SDZXF Comparison
Open Charts BNXTF vs SDZXFBanner chart's image
BIONXT SOLUTIONS
Price$0.17
Change+$0.01 (+6.25%)
Volume$10K
CapitalizationN/A
Sandoz Group AG
Price$44.83
Change-$0.80 (-1.75%)
Volume$212
CapitalizationN/A
BNXTF vs SDZXF Comparison Chart
Loading...
View a ticker or compare two or three
VS
BNXTF vs. SDZXF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNXTF is a Hold and SDZXF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BNXTF: $0.17 vs. SDZXF: $44.83)
Brand notoriety: BNXTF and SDZXF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BNXTF: 150% vs. SDZXF: 33%
Market capitalization -- BNXTF: $33.77M vs. SDZXF: $0
BNXTF [@Pharmaceuticals: Other] is valued at $33.77M. SDZXF’s [@Pharmaceuticals: Other] market capitalization is $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNXTF’s FA Score shows that 0 FA rating(s) are green whileSDZXF’s FA Score has 0 green FA rating(s).

  • BNXTF’s FA Score: 0 green, 5 red.
  • SDZXF’s FA Score: 0 green, 5 red.
According to our system of comparison, SDZXF is a better buy in the long-term than BNXTF.

Price Growth

BNXTF (@Pharmaceuticals: Other) experienced а -4.23% price change this week, while SDZXF (@Pharmaceuticals: Other) price change was -1.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

SDZXF is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
SDZXF YTD gains are higher at: 38.379 vs. BNXTF (-55.364).
BNXTFSDZXFBNXTF / SDZXF
Capitalization33.8MN/A-
EBITDA-11.29MN/A-
Gain YTD-55.36438.379-144%
P/E RatioN/AN/A-
Revenue346KN/A-
Total Cash1.89MN/A-
Total Debt4.61MN/A-
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IDOG29.150.10
+0.35%
ALPS International Sector Div Dogs ETF
NUSA22.990.02
+0.09%
Nuveen ESG 1-5 Year US Aggt Bd ETF
OUNZ24.72-0.05
-0.20%
VanEck Merk Gold Trust
FDLS32.39-0.22
-0.67%
Inspire Fidelis Multi Factor ETF
QUAL179.56-2.99
-1.64%
iShares MSCI USA Quality Factor ETF

BNXTF and

Correlation & Price change

A.I.dvisor tells us that BNXTF and TAK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNXTF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
+3.63%
TAK - BNXTF
32%
Poorly correlated
+0.37%
SNOA - BNXTF
29%
Poorly correlated
-0.77%
SDZXF - BNXTF
29%
Poorly correlated
-1.76%
ALVO - BNXTF
13%
Poorly correlated
-2.82%
ESAIY - BNXTF
11%
Poorly correlated
-5.26%
More

SDZXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SDZXF has been loosely correlated with SDZNY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SDZXF jumps, then SDZNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDZXF
1D Price
Change %
SDZXF100%
-1.76%
SDZNY - SDZXF
44%
Loosely correlated
+1.70%
BNXTF - SDZXF
29%
Poorly correlated
+3.63%
AGYTF - SDZXF
20%
Poorly correlated
N/A
CBSTF - SDZXF
6%
Poorly correlated
-4.42%
ESAIY - SDZXF
5%
Poorly correlated
-5.26%
More